Impact of age and vector construct on striatal and nigral transgene expression

Therapeutic protein delivery using viral vectors has shown promise in preclinical models of Parkinson’s disease (PD) but clinical trial success remains elusive. This may partially be due to a failure to include advanced age as a covariate despite aging being the primary risk factor for PD. We invest...

Descripción completa

Detalles Bibliográficos
Autores principales: Polinski, Nicole K, Manfredsson, Fredric P, Benskey, Matthew J, Fischer, D Luke, Kemp, Christopher J, Steece-Collier, Kathy, Sandoval, Ivette M, Paumier, Katrina L, Sortwell, Caryl E
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5142515/
https://www.ncbi.nlm.nih.gov/pubmed/27933309
http://dx.doi.org/10.1038/mtm.2016.82

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5142515/
https://www.ncbi.nlm.nih.gov/pubmed/27933309
http://dx.doi.org/10.1038/mtm.2016.82

Ejemplares similares